Published in Medical Letter on the CDC and FDA, August 3rd, 2008
Commenting on the announcement, Michael Adams, CEO and President, said, "We are pleased with the FDA's timely review and approval of our request to export the 4mm graft for use in our CardioPass(TM) European clinical trial. This important milestone provides a second graft size...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.